The silencing of lncRNA XIST negatively regulates miR-124 and positively regulates BACE1 expression in N2a cells, thus suggesting that lncRNA XIST may be a new potential target for AD treatment (Yue et al., 2020). The gene discussed is XIST; the disease is Alzheimer disease.